お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ
株式会社グローバルインフォメーション
表紙:心房中隔欠損症の世界市場:症状(呼吸困難、倦怠感、反復性呼吸器感染症、動悸、下肢の腫れ)別の予測(2025年まで)- COVID-19の累積的影響
市場調査レポート
商品コード
1001150

心房中隔欠損症の世界市場:症状(呼吸困難、倦怠感、反復性呼吸器感染症、動悸、下肢の腫れ)別の予測(2025年まで)- COVID-19の累積的影響

Atrial Septal Defect Market Research Report by Symptoms (Dyspnea, Fatigue, Frequent Respiratory Infections, Heart Palpitations, and Swelling Of Legs And Feet) - Global Forecast to 2025 - Cumulative Impact of COVID-19

出版日: | 発行: 360iResearch LLP | ページ情報: 英文 182 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=110.22円
心房中隔欠損症の世界市場:症状(呼吸困難、倦怠感、反復性呼吸器感染症、動悸、下肢の腫れ)別の予測(2025年まで)- COVID-19の累積的影響
出版日: 2021年04月13日
発行: 360iResearch LLP
ページ情報: 英文 182 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の心房中隔欠損症の市場規模は、2020年の47億9,067万米ドルから2025年末までに61億9,056万米ドルに拡大すると予想されています。

COVID-19は、ほぼすべての業界に影響を与えた未曾有の世界の公衆衛生上の緊急事態であるため、予測期間中に業界の成長に長期的な影響を与えると予測されています。当レポートでは、根底にあるCOVID-19の問題と今後の道筋を確実に扱うために、調査範囲を広げ消費者の行動と需要の変化、購入パターン、サプライチェーンの再ルーティング、現在の市場動向、および政府の重要な介入などを考慮しながら、COVID-19の影響について考察しています。

当レポートは、世界の心房中隔欠損症市場について調査しており、市場の機会や課題、成長および抑制要因、COVID-19の累積的影響、症状・地域別の市場分析、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 序文

  • 調査の目的
  • 市場セグメンテーションとカバレッジ
  • 調査期間
  • 通貨と価格
  • 言語
  • 制限事項
  • 利害関係者

第2章 調査手法

  • 調査プロセス
    • 定義:調査目的
    • 決定:調査設計
    • 準備:調査機器
    • 収集:データソース
    • 分析:データの解釈
    • 策定:データ検証
    • 公開:調査レポート
    • 繰り返し:レポートの更新
  • 調査の実行
    • 開始:調査プロセス
    • 計画:調査計画を作成する
    • 実行:調査を実施する
    • 検証:発見と分析
    • 出版物:調査報告
  • 調査の成果

第3章 エグゼクティブサマリー

  • 市場展望
  • 症状別市場の展望
  • 地域別市場の展望
  • 競合他社の見通し

第4章 市場概要

  • COVID-19の累積的影響

第5章 市場の洞察

  • 市場力学
    • 成長要因
    • 抑制要因
    • 市場機会
    • 課題
  • ポーターのファイブフォース分析

第6章 症状別市場

  • 呼吸困難
  • 倦怠感
  • 反復性呼吸器感染症
  • 動悸
  • 下肢の腫れ

第7章 南北アメリカ市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第8章 アジア太平洋地域市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • 韓国
  • タイ

第9章 欧州、中東・アフリカ市場

  • フランス
  • ドイツ
  • イタリア
  • オランダ
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • アラブ首長国連邦
  • 英国

第10章 競合情勢

  • FPNVポジショニングマトリックス
    • 象限
    • 事業戦略
    • 製品の満足度
  • 市場ランキング分析
  • 市場シェア分析
  • 競合他社のSWOT分析
  • 競合シナリオ
    • 合併・買収
    • 合意、コラボレーション、およびパートナーシップ
    • 新製品の発売と強化
    • 投資と資金調達
    • 評価、認知、拡大

第11章 企業プロファイル

  • Abbott Laboratories
  • Actelion Ltd
  • Asklepion Pharmaceuticals, LLC
  • AtriCure, Inc
  • Biosense Webster, Inc.
  • Boston Scientific Corporation
  • Carag AG
  • Comed B.V.
  • Edwards Lifesciences
  • GE Healthcare
  • INO Therapeutics, LLC
  • Lepu Medical Technology (Beijing) Co., Ltd
  • Lifetech Scientific
  • Mallow Primary Healthcare Centre
  • Medtronic PLC
  • MicroPort Scientific Corp
  • Novo Nordisk A/S
  • Numed, Inc.
  • Occlutech GmbH
  • pfm medical AG
  • Siemens Healthineers AG
  • St. Jude Medical, Inc
  • Toshiba Corporation
  • W. L. Gore & Associates, Inc.

第12章 付録

  • ディスカッションガイド
  • ライセンスと価格
図表

LIST OF FIGURES

  • FIGURE 1. GLOBAL ATRIAL SEPTAL DEFECT MARKET: RESEARCH PROCESS
  • FIGURE 2. GLOBAL ATRIAL SEPTAL DEFECT MARKET: RESEARCH EXECUTION
  • FIGURE 3. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, 2020 VS 2025 (USD MILLION)
  • FIGURE 4. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS , 2020 (USD MILLION)
  • FIGURE 5. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
  • FIGURE 6. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, 2018-2025 (USD MILLION)
  • FIGURE 7. GLOBAL ATRIAL SEPTAL DEFECT MARKET: MARKET DYNAMICS
  • FIGURE 8. GLOBAL ATRIAL SEPTAL DEFECT MARKET: PORTERS FIVE FORCES ANALYSIS
  • FIGURE 9. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS , 2020 VS 2025 (%)
  • FIGURE 10. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS , 2020 VS 2025 (USD MILLION)
  • FIGURE 11. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS , 2025
  • FIGURE 12. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY DYSPNEA, 2020 VS 2025 (USD MILLION)
  • FIGURE 13. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY FATIGUE, 2020 VS 2025 (USD MILLION)
  • FIGURE 14. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY FREQUENT RESPIRATORY INFECTIONS, 2020 VS 2025 (USD MILLION)
  • FIGURE 15. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY HEART PALPITATIONS, 2020 VS 2025 (USD MILLION)
  • FIGURE 16. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY SWELLING OF LEGS AND FEET, 2020 VS 2025 (USD MILLION)
  • FIGURE 17. AMERICAS ATRIAL SEPTAL DEFECT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
  • FIGURE 18. AMERICAS ATRIAL SEPTAL DEFECT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
  • FIGURE 19. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS ATRIAL SEPTAL DEFECT MARKET SIZE, BY GEOGRAPHY, 2025
  • FIGURE 20. ARGENTINA ATRIAL SEPTAL DEFECT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 21. BRAZIL ATRIAL SEPTAL DEFECT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 22. CANADA ATRIAL SEPTAL DEFECT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 23. MEXICO ATRIAL SEPTAL DEFECT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 24. UNITED STATES ATRIAL SEPTAL DEFECT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 25. ASIA-PACIFIC ATRIAL SEPTAL DEFECT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
  • FIGURE 26. ASIA-PACIFIC ATRIAL SEPTAL DEFECT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
  • FIGURE 27. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC ATRIAL SEPTAL DEFECT MARKET SIZE, BY GEOGRAPHY, 2025
  • FIGURE 28. AUSTRALIA ATRIAL SEPTAL DEFECT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 29. CHINA ATRIAL SEPTAL DEFECT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 30. INDIA ATRIAL SEPTAL DEFECT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 31. INDONESIA ATRIAL SEPTAL DEFECT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 32. JAPAN ATRIAL SEPTAL DEFECT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 33. MALAYSIA ATRIAL SEPTAL DEFECT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 34. PHILIPPINES ATRIAL SEPTAL DEFECT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 35. SOUTH KOREA ATRIAL SEPTAL DEFECT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 36. THAILAND ATRIAL SEPTAL DEFECT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 37. EUROPE, MIDDLE EAST & AFRICA ATRIAL SEPTAL DEFECT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
  • FIGURE 38. EUROPE, MIDDLE EAST & AFRICA ATRIAL SEPTAL DEFECT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
  • FIGURE 39. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA ATRIAL SEPTAL DEFECT MARKET SIZE, BY GEOGRAPHY, 2025
  • FIGURE 40. FRANCE ATRIAL SEPTAL DEFECT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 41. GERMANY ATRIAL SEPTAL DEFECT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 42. ITALY ATRIAL SEPTAL DEFECT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 43. NETHERLANDS ATRIAL SEPTAL DEFECT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 44. QATAR ATRIAL SEPTAL DEFECT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 45. RUSSIA ATRIAL SEPTAL DEFECT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 46. SAUDI ARABIA ATRIAL SEPTAL DEFECT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 47. SOUTH AFRICA ATRIAL SEPTAL DEFECT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 48. SPAIN ATRIAL SEPTAL DEFECT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 49. UNITED ARAB EMIRATES ATRIAL SEPTAL DEFECT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 50. UNITED KINGDOM ATRIAL SEPTAL DEFECT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 51. GLOBAL ATRIAL SEPTAL DEFECT MARKET: FPNV POSITIONING MATRIX
  • FIGURE 52. GLOBAL ATRIAL SEPTAL DEFECT MARKET: MARKET SHARE ANALYSIS
  • FIGURE 53. GLOBAL ATRIAL SEPTAL DEFECT MARKET: COMPETITOR SWOT ANALYSIS
  • FIGURE 54. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL ATRIAL SEPTAL DEFECT MARKET, BY TYPE

LIST OF TABLES

  • TABLE 1. CURRENCY CONVERSION RATES
  • TABLE 2. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 3. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS , 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 4. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY DYSPNEA, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 5. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY FATIGUE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 6. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY FREQUENT RESPIRATORY INFECTIONS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 7. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY HEART PALPITATIONS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 8. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY SWELLING OF LEGS AND FEET, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 9. AMERICAS ATRIAL SEPTAL DEFECT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 10. AMERICAS ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS , 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 11. ARGENTINA ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS , 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 12. BRAZIL ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS , 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 13. CANADA ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS , 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 14. MEXICO ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS , 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 15. UNITED STATES ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS , 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 16. ASIA-PACIFIC ATRIAL SEPTAL DEFECT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 17. ASIA-PACIFIC ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS , 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 18. AUSTRALIA ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS , 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 19. CHINA ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS , 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 20. INDIA ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS , 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 21. INDONESIA ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS , 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 22. JAPAN ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS , 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 23. MALAYSIA ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS , 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 24. PHILIPPINES ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS , 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 25. SOUTH KOREA ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS , 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 26. THAILAND ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS , 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 27. EUROPE, MIDDLE EAST & AFRICA ATRIAL SEPTAL DEFECT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 28. EUROPE, MIDDLE EAST & AFRICA ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS , 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 29. FRANCE ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS , 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 30. GERMANY ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS , 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 31. ITALY ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS , 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 32. NETHERLANDS ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS , 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 33. QATAR ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS , 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 34. RUSSIA ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS , 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 35. SAUDI ARABIA ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS , 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 36. SOUTH AFRICA ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS , 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 37. SPAIN ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS , 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 38. UNITED ARAB EMIRATES ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS , 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 39. UNITED KINGDOM ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS , 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 40. GLOBAL ATRIAL SEPTAL DEFECT MARKET: SCORES
  • TABLE 41. GLOBAL ATRIAL SEPTAL DEFECT MARKET: BUSINESS STRATEGY
  • TABLE 42. GLOBAL ATRIAL SEPTAL DEFECT MARKET: PRODUCT SATISFACTION
  • TABLE 43. GLOBAL ATRIAL SEPTAL DEFECT MARKET: RANKING
  • TABLE 44. GLOBAL ATRIAL SEPTAL DEFECT MARKET: MERGER & ACQUISITION
  • TABLE 45. GLOBAL ATRIAL SEPTAL DEFECT MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
  • TABLE 46. GLOBAL ATRIAL SEPTAL DEFECT MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
  • TABLE 47. GLOBAL ATRIAL SEPTAL DEFECT MARKET: INVESTMENT & FUNDING
  • TABLE 48. GLOBAL ATRIAL SEPTAL DEFECT MARKET: AWARD, RECOGNITION, & EXPANSION
  • TABLE 49. GLOBAL ATRIAL SEPTAL DEFECT MARKET: LICENSE & PRICING
目次
Product Code: MRR-905E9D5

Market Statistics

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.

  • 1. The Global Atrial Septal Defect Market is expected to grow from USD 4,790.67 Million in 2020 to USD 6,190.56 Million by the end of 2025.
  • 2. The Global Atrial Septal Defect Market is expected to grow from EUR 4,200.55 Million in 2020 to EUR 5,428.00 Million by the end of 2025.
  • 3. The Global Atrial Septal Defect Market is expected to grow from GBP 3,734.29 Million in 2020 to GBP 4,825.50 Million by the end of 2025.
  • 4. The Global Atrial Septal Defect Market is expected to grow from JPY 511,285.88 Million in 2020 to JPY 660,689.62 Million by the end of 2025.
  • 5. The Global Atrial Septal Defect Market is expected to grow from AUD 6,956.68 Million in 2020 to AUD 8,989.51 Million by the end of 2025.

Market Segmentation & Coverage

This research report categorizes the Atrial Septal Defect to forecast the revenues and analyze the trends in each of the following sub-markets:

  • Based on Symptoms , the Atrial Septal Defect Market studied across Dyspnea, Fatigue, Frequent Respiratory Infections, Heart Palpitations, and Swelling Of Legs And Feet.
  • Based on Geography, the Atrial Septal Defect Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Company Usability Profiles

The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Atrial Septal Defect Market including Abbott Laboratories, Actelion Ltd, Asklepion Pharmaceuticals, LLC, AtriCure, Inc, Biosense Webster, Inc., Boston Scientific Corporation, Carag AG, Comed B.V., Edwards Lifesciences, GE Healthcare, INO Therapeutics, LLC, Lepu Medical Technology (Beijing) Co., Ltd, Lifetech Scientific, Mallow Primary Healthcare Centre, Medtronic PLC, MicroPort Scientific Corp, Novo Nordisk A/S, Numed, Inc., Occlutech GmbH, pfm medical AG, Siemens Healthineers AG, St. Jude Medical, Inc, Toshiba Corporation, and W. L. Gore & Associates, Inc..

Cumulative Impact of COVID-19

COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.

360iResearch™FPNV Positioning Matrix

The 360iResearch™ FPNV Positioning Matrix evaluates and categorizes the vendors in the Atrial Septal Defect Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

360iResearch™Competitive Strategic Window

The 360iResearch™ Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The 360iResearch™ Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.

The report provides insights on the following pointers:

  • 1. Market Penetration: Provides comprehensive information on the market offered by the key players
  • 2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
  • 3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
  • 4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
  • 5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments

The report answers questions such as:

  • 1. What is the market size and forecast of the Global Atrial Septal Defect Market?
  • 2. What are the inhibiting factors and impact of COVID-19 shaping the Global Atrial Septal Defect Market during the forecast period?
  • 3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Atrial Septal Defect Market?
  • 4. What is the competitive strategic window for opportunities in the Global Atrial Septal Defect Market?
  • 5. What are the technology trends and regulatory frameworks in the Global Atrial Septal Defect Market?
  • 6. What are the modes and strategic moves considered suitable for entering the Global Atrial Septal Defect Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Stakeholders

2. Research Methodology

  • 2.1. Research Process
    • 2.1.1. Define: Research Objective
    • 2.1.2. Determine: Research Design
    • 2.1.3. Prepare: Research Instrument
    • 2.1.4. Collect: Data Source
    • 2.1.5. Analyze: Data Interpretation
    • 2.1.6. Formulate: Data Verification
    • 2.1.7. Publish: Research Report
    • 2.1.8. Repeat: Report Update
  • 2.2. Research Execution
    • 2.2.1. Initiation: Research Process
    • 2.2.2. Planning: Develop Research Plan
    • 2.2.3. Execution: Conduct Research
    • 2.2.4. Verification: Finding & Analysis
    • 2.2.5. Publication: Research Report
  • 2.3. Research Outcome

3. Executive Summary

  • 3.1. Introduction
  • 3.2. Market Outlook
  • 3.3. Symptoms Outlook
  • 3.4. Geography Outlook
  • 3.5. Competitor Outlook

4. Market Overview

  • 4.1. Introduction
  • 4.2. Cumulative Impact of COVID-19

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalences of genetic heart disorders
      • 5.1.1.2. Growing awareness regarding atrial septal defects among the population
      • 5.1.1.3. Adoption of MRI procedures
    • 5.1.2. Restraints
      • 5.1.2.1. High cost associated with the devices to carry out the procedure
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancement in the treatment of congenital heart diseases
      • 5.1.3.2. Favorable government reimbursements and growing disposable income
    • 5.1.4. Challenges
      • 5.1.4.1. Heart defect closure device-related limitations
      • 5.1.4.2. Possible risk factors for erosion after ASD closure with the Amplatzer septal occluder device
  • 5.2. Porters Five Forces Analysis
    • 5.2.1. Threat of New Entrants
    • 5.2.2. Threat of Substitutes
    • 5.2.3. Bargaining Power of Customers
    • 5.2.4. Bargaining Power of Suppliers
    • 5.2.5. Industry Rivalry

6. Global Atrial Septal Defect Market, By Symptoms

  • 6.1. Introduction
  • 6.2. Dyspnea
  • 6.3. Fatigue
  • 6.4. Frequent Respiratory Infections
  • 6.5. Heart Palpitations
  • 6.6. Swelling Of Legs And Feet

7. Americas Atrial Septal Defect Market

  • 7.1. Introduction
  • 7.2. Argentina
  • 7.3. Brazil
  • 7.4. Canada
  • 7.5. Mexico
  • 7.6. United States

8. Asia-Pacific Atrial Septal Defect Market

  • 8.1. Introduction
  • 8.2. Australia
  • 8.3. China
  • 8.4. India
  • 8.5. Indonesia
  • 8.6. Japan
  • 8.7. Malaysia
  • 8.8. Philippines
  • 8.9. South Korea
  • 8.10. Thailand

9. Europe, Middle East & Africa Atrial Septal Defect Market

  • 9.1. Introduction
  • 9.2. France
  • 9.3. Germany
  • 9.4. Italy
  • 9.5. Netherlands
  • 9.6. Qatar
  • 9.7. Russia
  • 9.8. Saudi Arabia
  • 9.9. South Africa
  • 9.10. Spain
  • 9.11. United Arab Emirates
  • 9.12. United Kingdom

10. Competitive Landscape

  • 10.1. FPNV Positioning Matrix
    • 10.1.1. Quadrants
    • 10.1.2. Business Strategy
    • 10.1.3. Product Satisfaction
  • 10.2. Market Ranking Analysis
  • 10.3. Market Share Analysis
  • 10.4. Competitor SWOT Analysis
  • 10.5. Competitive Scenario
    • 10.5.1. Merger & Acquisition
    • 10.5.2. Agreement, Collaboration, & Partnership
    • 10.5.3. New Product Launch & Enhancement
    • 10.5.4. Investment & Funding
    • 10.5.5. Award, Recognition, & Expansion

11. Company Usability Profiles

  • 11.1. Abbott Laboratories
  • 11.2. Actelion Ltd
  • 11.3. Asklepion Pharmaceuticals, LLC
  • 11.4. AtriCure, Inc
  • 11.5. Biosense Webster, Inc.
  • 11.6. Boston Scientific Corporation
  • 11.7. Carag AG
  • 11.8. Comed B.V.
  • 11.9. Edwards Lifesciences
  • 11.10. GE Healthcare
  • 11.11. INO Therapeutics, LLC
  • 11.12. Lepu Medical Technology (Beijing) Co., Ltd
  • 11.13. Lifetech Scientific
  • 11.14. Mallow Primary Healthcare Centre
  • 11.15. Medtronic PLC
  • 11.16. MicroPort Scientific Corp
  • 11.17. Novo Nordisk A/S
  • 11.18. Numed, Inc.
  • 11.19. Occlutech GmbH
  • 11.20. pfm medical AG
  • 11.21. Siemens Healthineers AG
  • 11.22. St. Jude Medical, Inc
  • 11.23. Toshiba Corporation
  • 11.24. W. L. Gore & Associates, Inc.

12. Appendix

  • 12.1. Discussion Guide
  • 12.2. License & Pricing
株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.